Navigation Links
Prous Institute Presents Innovative Approach to Drug Discovery
Date:2/26/2009

BARCELONA, February 26 /PRNewswire/ -- Prous Institute for Biomedical Research today presented its strategies for drug discovery on its newly designed website (http://www.prousresearch.com). A large computational project with basic research support and broad disease coverage is being developed at Prous Institute under the broad-based Epistemic Drug Discovery(R) project.

President and C.E.O. of the Institute, Dr. J.R. Prous, explained that "We are committed to accelerating biomedical knowledge by the synchronization of powerful expert knowledge-based systems and basic research. This next-generation drug R&D force is expected to increase the efficiency and efficacy of core drug R&D processes, facilitating continuous innovation."

Two main drug discovery programs are being developed at the Institute. One is focused on the design, synthesis and biological evaluation of new small-molecule modulators of autophagy as therapeutic agents for cancer and neurodegeneration (Alzheimer's disease and Huntington's disease). Another program looks at target-driven drug discovery from natural sources, covering type 2 diabetes, psychological stress and asthma. The Institute's computational tools enable the in silico screening of thousands of natural products in a rapid, reliable and cost-effective manner, as well as the discovery of new targets and new uses for existing drugs.

J.R. Prous commented "our approach is bringing us closer to drug discovery, and the Institute expects to have several compounds in preclinical evaluation by the end of this year (2009)."

About Prous Institute for Biomedical Research

Prous Institute is a privately-held research-driven organization committed to the discovery and development of innovative therapies through the use of its powerful computational tools and the support of basic research. P
'/>"/>

SOURCE Prous Institute for Biomedical Research, S.A.
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related biology technology :

1. ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria
2. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
3. UKs Institute of Cancer Research and Silicon Graphics Establish Long-Term Alliance to Design and Outfit World-Class Network Biology Lab
4. American Institute for Medical and Biological Engineering Appoints Dr. Gualberto Ruano to College of Fellows
5. Baltimore LASIK Surgeon Roy Chuck, MD, PhD of the Wilmer Eye Institute at Johns Hopkins Lists with Trusted LASIK Surgeons
6. Agendias Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
7. IDRI Collaborates with the Brazilian Butantan Institute To Develop Novel Vaccines Against Leishmaniasis
8. National Cancer Institute: Battling Cancer and a Recession
9. The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates
10. Pressure BioSciences, Inc. and the J. Craig Venter Institute Announce Collaboration Agreement & Purchase of a PCT System
11. Cascades Technologies, Inc. and SAIC Team on $19 Million Contract with National Institutes of Health

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...o also Visit Detroit , (V...French Ambassador for International Investment, an... , , , ,What: Ambassador Appia is available to me...atives adopted by France to further develop the fi...ion and development., , ,When: Available for Inter...
(Date:11/24/2009)...rio, Nov. 24 Dow AgroSci...ssets of Hyland Seeds, a division of Thompsons Lim...Seeds will further expand Dow AgroSciences, curren...troduction of SmartStax(TM) in 2010 and Dow ...n corn in 2012. The transactional close is expecte...
(Date:11/24/2009)... employment grew by 29,000 jobs in October, and t...rowth during the U.S. recession. However, clinics ...lth systems are coming closer to having to actuall...ators. , (Vocus) November...ing in October despite the shedding of jobs in mos...
(Date:11/24/2009).... 24 NeurogesX, Inc. (Na... on developing and commercializing novel pain mana...onno, President and Chief Executive Officer, is sc...y Health Care Conference, to be held December 1-2,...w York. ,, Mr. DiTonno and Stephen Ghiglieri, ...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...rocessing Services selected BMC Software ,s MAIN...esponse time of its credit card and credit applica...ervices provides outsourced credit receivables man...Fiserv Credit Processing Services provides clients...nage credit decisions, account acquisition, accoun...
...many ways to share information. But most of us rel...oint. , ,We all use portals of various types. News...hat portals. Some of us use project management, da...all these are now available not only as stand alon...ns that are available 24/7. , ,The problem is tha...
...tion , a global supply chain technology solutions ...a-Pacific headquarters in Shanghai, China. With an...sixty employees by the end of 2004. The office is ...t development for the Far East. RedPrairie is the ...adquarters in China. , ,"Creating a strong presen...
Other Biology Technology:E-Mail Collaboration Problems 2E-Mail Collaboration Problems 3E-Mail Collaboration Problems 4
(Date:11/24/2009)...upus Research Institute (LRI) today named 12 new g...6 million, recognize innovative work across a broa...r their creativity, novelty, and potential to driv...t, and cure the complex disease of systemic lupus....d lupus researchers across the nation and include ...
(Date:11/24/2009)...ger and the American College of Medical Toxicology... the publication of the Journal of Medical Toxico...inning in March 2010. It was previously published... Journal of Medical Toxicology , an international... the science and practice of medical toxicology. ...
(Date:11/24/2009)... release is available in Spanish . , The pr... levels of inflammatory substances in the blood, h... shown by a research project of the University of ...cientist at the School of Pharmacy. , The projec... in relation to the control of body weight and inf...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 1US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 2US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 3US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 4US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 5US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 6US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 7New biofactories produce rare healing substances in the endangered Devils claw plant 54597 1New biofactories produce rare healing substances in the endangered Devils claw plant 54597 2New biofactories produce rare healing substances in the endangered Devils claw plant 54597 3Newly found DNA catalysts cleave DNA with water molecule 9589 1Newly found DNA catalysts cleave DNA with water molecule 9589 2
...in a key brain protein known to underlie a form of...nting the normal growth and branching of neurons, ...alfunction of the protein made by mutant forms of ...ultimately leading to their death. The loss of dop...y of PD, and loss of connections among such neuron...
... simple stream of one-letter characters in the hum...de. In order to decipher this level of architectu...ental and algorithmic methods to detect copy numbe...duplications of DNA segments. These technologies-...were used to create the first comprehensive map of...
...g reasons behind the dramatic increase in testicul...ong 15-to-35-year-old Caucasian men, is the focus ...tute (NCI) grant to Yale Public Health researcher ... for unknown reasons and this study will provide i...netic and other risk factors,?said Zheng, professo...
Other Biology News:Parkinson's mutation stunts neurons 2New technology used to construct the first map of structural variation in the human genome 2
...53; Agarose Gel-Digesting Preparation contains a u... EPICENTRE for simple, quantitative recovery of in...ose gels following electrophoresis in TAE, TBE, MO...directly in the TAE, TBE, MOPS, and phosphate elec...
...heer in-house demand is causing shortages in your ...s antibody. This can cause unwanted distractions, ...for your hard work and endeavour! Bring us your id...nally. We work under ISO 9001 quality assurance in...
...assays for interferons are cytopathic effect inhib...ys. Sample types include; tissue culture supernat...ons. In these assays, one unit is defined as the ...reduce the cytopathic effect of viral infection by...
Mae II from Roche Applied Science
Biology Products: